Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
The company on 17 November 2025 released a presentation in which it detailed the much-anticipated feedback from the Food and Drug Administration (FDA) on its Galidesivir programme for Marburg.
The feedback was very positive for ILA in that two outstanding matters were resolved: 1.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.